Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A

Environmental Health Perspectives

Volumn 119, Issue 9, 2011, Pages 1227-1232

  Riu, Anne ^a   Grimaldi, Marina ^b,c,d,e   le Maire, Albane ^d,f   Bey, Gilbert ^g   Phillips, Kevin ^h   Boulahtouf, Abdelhay ^b,c,d,e   Perdu, Elisabeth ^a   Zalko, Daniel ^a   Bourguet, William ^d,f   Balaguer, Patrick ^b,c,d,e  

^a CEMAGREF   (France)

^b INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^c INSERM   (France)

^d UNIV MONTPELLIER   (France)

^e CENTRE VAL D AURELLE   (France)

^f CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^g NovAliX   (France)

^h HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

BPA; Endocrine disruptor; Obesity; Ppar ; Tbbpa; Tcbpa

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TETRABROMOBISPHENOL A; TETRACHLOROBISPHENOL A; TRITIUM; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; ESTROGEN ACTIVITY; HALOGENATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR BINDING; XENOPUS; ZEBRA FISH;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; CHLOROPHENOLS; CRYSTALLOGRAPHY, X-RAY; ENDOCRINE DISRUPTORS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS, NON-STEROIDAL; FLAME RETARDANTS; HUMANS; LIGANDS; POLYBROMINATED BIPHENYLS; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; XENOPUS; ZEBRAFISH;

ANIMALIA; DANIO RERIO;

EID: 80052305965     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1003328     Document Type: Article

References (42)

1. Afonine PV, Grosse-Kunstleve RW, Adams PD. 2005. A robust bulk-solvent correction and anisotropic scaling procedure. Acta Crystallogra 61(7):850-855.
2. Arbeli Z, Ronen Z, Diaz-Baez MC. 2006. Reductive dehalogenation of tetrabromobisphenol-A by sediment from a contaminated ephemeral streambed and an enrichment culture. Chemosphere 64(9):1472-1478.
3. Bourguet W, Germain P, Gronemeyer H. 2000. Nuclear receptor ligand-binding domains: three dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci 21(10):381-388.
4. Bruning JB, Chalmers MJ, Prasad S, Busby SA, Kamenecka TM, He Y, et al. 2007. Partial agonists activate PPARγ using a helix 12 independent mechanism. Structure 15(10):1258-1271.
5. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116:39-44.
6. Cariou R, Antignac JP, Zalko D, Berrebi A, Cravedi JP, Maume D, et al. 2008. Exposure assessment of French women and their newborns to tetrabromobisphenol-A: occurrence measurements in maternal adipose tissue, serum, breast milk and cord serum. Chemosphere 73(7):1036-1041.
7. Chu S, Haffner GD, Letcher RJ. 2005. Simultaneous determination of tetrabromobisphenol A, tetrachlorobisphenol A, bisphenol A and other halogenated analogues in sediment and sludge by high performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 1097(1-2):25-32.
8. Collaborative Computational Project, Number 4. 1994. The CCP4 Suite: Programs for Protein Crystallography. Acta Crystallogr D Biol Crystallogr 50:760-763.
9. Darnerud PO. 2003. Toxic effects of brominated flame retardants in man and in wildlife. Environ Int 29(6):841-853.
10. Deborde M, Rabouan S, Gallard H, Legube B. 2004. Aqueous chlorination kinetics of some endocrine disruptors. Environ Sci Technol 38(21):5577-5583.
11. de Wit CA, Herzke D, Vorkamp K. 2010. Brominated flame retardants in the Arctic environment-trends and new candidates. Sci Total Environ 408(15):2885-2918.
12. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr 60:2126-2132.
13. Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, et al. 2006. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol 71(10):1459-1469.
14. Feige JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C, et al. 2007. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 282(26):19152-19166.
15. Fernandez MF, Arrebola JP, Taoufiki J, Navalon A, Ballesteros O, Pulgar R, et al. 2007. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 24(2):259-264.
16. Fini JB, Le Mevel S, Turque N, Palmier K, Zalko D, Cravedi JP, et al. 2007. An in vivo multiwell-based fluorescent screen for monitoring vertebrate thyroid hormone disruption. Environ Sci Technol 41(16):5908-5914.
17. Fukazawa H, Hoshino K, Shiozawa T, Matsushita H, Terao Y. 2001. Identification and quantification of chlorinated bisphenol A in wastewater from wastepaper recycling plants. Chemosphere 44(5):973-979.
18. Grün F, Blumberg B. 2006. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(suppl 6):S50-S55.
19. Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, et al. 2006. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20:2141-2155.
20. Guerra P, Eljarrat E, Barcelo D. 2010. Simultaneous determination of hexabromocyclododecane, tetrabromobisphenol A, and related compounds in sewage sludge and sediment samples from Ebro River basin (Spain). Anal Bioanal Chem 397(7):2817-2824.
21. Kallenberger BC, Love JD, Chatterjee VK, Schwabe JW. 2003. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Nature Struct Biol 10(2):136-140.
22. Kitamura S, Jinno N, Ohta S, Kuroki H, Fujimoto N. 2002. Thyroid hormonal activity of the flame retardants tetrabromobisphenol A and tetrachlorobisphenol A. Biochem Biophys Res Commun 293(1):554-559.
23. Legler J, Zeinstra LM, Schuitemaker F, Lanser PH, Bogerd J, Brouwer A, et al. 2002. Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environ Sci Technol 36(20):4410-4415.
24. le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat-Hannah V, Balaguer P, et al. 2009. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Rep 10(4):367-373.
25. Leslie AGW. 2006. The integration of macromolecular diffraction data. Acta Crystallograph D Biol Crystallogr 62:48-57.
26. Meerts IA, Letcher RJ, Hoving S, Marsh G, Bergman A, Lemmen JG, et al. 2001. In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds. Environ Health Perspect 109:399-407.
27. Mutou Y, Ibuki Y, Terao Y, Kojima S, Goto R. 2006. Change of estrogenic activity and release of chloride ion in chlorinated bisphenol A after exposure to ultraviolet B. Biol Pharm Bull 29(10):2116-2119.
28. Nahoum V, Perez E, Germain P, Rodriguez-Barrios F, Manzo F, Kammerer S, et al. 2007. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function. Proc Natl Acad Sci USA 104(44):17323-17328.
29. Nakagawa Y, Suzuki T, Ishii H, Ogata A. 2007. Biotransformation and cytotoxicity of a brominated flame retardant, tetrabromobisphenol A, and its analogues in rat hepatocytes. Xenobiotica 37(7):693-708.
30. Newbold RR, Jefferson WN, Padilla-Banks E. 2009. Prenatal exposure to bisphenol A at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect 117:879-885.
31. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, et al. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395(6698):137-143.
32. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. 2007. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24(2):199-224.
33. Rubin BS, Soto AM. 2009. Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 304(1-2):55-62.
34. Shi ZX, Wu YN, Li JG, Zhao YF, Feng JF. 2009. Dietary exposure assessment of Chinese adults and nursing infants to tetrabromobisphenol-A and hexabromocyclododecanes: occurrence measurements in foods and human milk. Environ Sci Technol 43(12):4314-4319.
35. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S, et al. 2009. Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environ Health Perspect 117:1549-1555.
36. Swedenborg E, Ruegg J, Makela S, Pongratz I. 2009. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J Mol Endocrinol 43(1):1-10.
37. Takacs ML, Abbott BD. 2007. Activation of mouse and human peroxisome proliferator-activated receptors (α, β/ δ, γ) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci 95(1) 108-117.
38. Takemura H, Ma J, Sayama K, Terao Y, Zhu BT, Shimoi K. 2005. In vitro and in vivo estrogenic activity of chlorinated derivatives of bisphenol A. Toxicology 207(2):215-221.
39. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30(1):75-95.
40. vom Saal FS, Hughes C. 2005. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113:926-933.
41. Waku T, Shiraki T, Oyama T, Fujimoto Y, Maebara K, Kamiya N, et al. 2009. Structural insight into PPARγ activation through covalent modification with endogenous fatty acids. J Mol Biol 385(1):188-199.
42. Zalko D, Prouillac C, Riu A, Perdu E, Dolo L, Jouanin I, et al. 2006. Biotransformation of the flame retardant tetrabromo-bisphenol A by human and rat sub-cellular liver fractions. Chemosphere 64(2):318-327.